A new carotid artery transplantation model of rats

Abstract

To establish a murine carotid artery transplantation model for the study of the chronic rejection, 80 rats were divided into two groups, an allotransplant (ACI-Lewis) group and an isotransplant (Lewis-Lewis) group (control group). The donor carotid artery and the recipient carotid artery were anastomosed by using a polyethylene cuff (internal diameter: 0.7 mm, length: 3 mm).The pathological changes of carotid artery transplant were observed 14, 28 and 56 days after the transplantation. The results showed that the model was successfully established in 95% of the animals. The chronic rejection-associated arteriosclerosis was induced 28 days after the transplantation. The new chronic rejection model of carotid artery by using cuff technique caused fewer traumas and was easy to make. The pathological changes of the transplant mimicked the chronic rejection-associated arteriosclerosis found in human transplant.

Keywords

chronic rejection / animal model / transplant arteriosclerosis / rats

References

[1] QianZ., HuW., LiuJ., et al. . Accelerated graft arteriosclerosis in cardiac transplants: complement activation promotes progression of lesions from medium to large arteries. Transplantation, 2001, 72(5): 900-906

[2] RossM., KouretasP., GambergP., et al. . Ten- and 20-year survivors of pediatric orthotopic heart transplantation. J Heart Lung Transplant, 2006, 25(3): 261-270

[3] SipahiI., StarlingR.C.. Cardiac allograft vasculopathy: an update. Heart Fail Clin, 2007, 3(1): 87-95

[4] SaiS., IwataA., ThomasR., et al. . Vascular cell adhesion molecule-1 up-regulation and phenotypic modulation of vascular smooth muscle cells predate mononuclear infiltration in transplant arteriopathy. J Thorac Cardiovasc Surg, 2001, 122(3): 508-517

[5] LogarC.M., HerzogC.A., BeddhuS.. Diagnosis and therapy of coronary artery disease in renal failure, end-stage renal disease, and renal transplant populations. Am J Med Sci, 2003, 325(4): 214-227

[6] KaczmarekI., DeutschM.A., KaukeT., et al. . Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant. Exp Clin Transplant, 2008, 6(3): 229-235

[7] TorsneyE., HuY., XuQ.. Adventitial progenitor cells contribute to arteriosclerosis. Trends Cardiovasc Med, 2005, 15(2): 64-68

[8] GrauhanO., PatzurekJ., HummelM., et al. . Donor-transmitted coronary atherosclerosis. J Heart Lung Transplant, 2003, 22(5): 568-573

[9] VamvakopoulosJ.E., PetrovL., AavikS., et al. . Synergistic suppression of rat neointimal hyperplasia by rapamycin and imatinib mesylate: implications for the prevention of accelerated arteriosclerosis. J Vasc Res, 2006, 43(2): 184-192

[10] RamzyD., RaoV., BrahmJ., et al. . Cardiac allograft vasculopathy: a review. Can J Surg, 2005, 48(4): 319-327

[11] MennanderA., TiisalaS., HalttunenJ., et al. . Chronic rejection in rat aortic allografts: an experimental model for transplant arteriosclerosis. Arterioscle Thromb, 1991, 11(2): 671-680

[12] ColeO.J., StubingtonS.R., RiggK.M., et al. . An experimental model of ischemia-produced transplant arteriosclerosis. Transplant Proc, 1998, 30(4): 1020

[13] GabrielM., FandrichF.. Estimation of graft arteriosclerosis after allogeneic fresh and cryopreserved aortic transplantation in the rat. Transplant Proc, 2002, 34(2): 711-712

[14] OnutaG., RienstraH., de BoerJ.F., et al. . Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats. Transplantation, 2007, 84(4): 517-526

[15] MatsumotoY., HofA., BaumlinY., et al. . Differential effects of everolimus and cyclosporine A on intimal alpha-actin-positive cell dynamics of carotid allografts in mice. Transplantation, 2004, 78(3): 345-351